Skip to main content
Drug bottle and Pill

Compare Eucrisa vs. Dupixent

Head-to-head comparisons of medication uses, side effects, warnings, and more.

Key takeaways

Eucrisa (crisaborole) and Dupixent (dupilumab) are both used to treat eczema, but they have some key differences. Eucrisa is a topical ointment that you apply to your skin, while Dupixent is an injectable medication. Eucrisa works by blocking the phosphodiesterase 4 (PDE4) enzyme to reduce inflammation and itching, and it's safe for children as young as 3 months. On the other hand, Dupixent is a monoclonal antibody that targets specific proteins to calm the immune system and is approved for children as young as 6 months. Both Dupixent and Eucrisa are only available as brand medications, but Dupixent is an injection, making it potentially more expensive. Additionally, Dupixent treats a wider range of conditions, including asthma and sinus congestion with nasal polyps, and is administered every other week or monthly, compared to Eucrisa's twice-daily application. Common side effects of Eucrisa include application site pain, while Dupixent can cause injection site reactions and eye inflammation.

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.